A patient with long-term, unrecognized leishmaniasis;Een patiënt met jarenlang niet onderkende mucocutane leishmaniasis

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 49, 2006, Pages 2715-2719

  Rabelink, N M ^a,b   De Steenwinkel, J E M ^a   Van Biezen, P ^a   Van Daele, P L A ^a,c   Gyssens, I C ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Afd Immunologie ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

STIBOGLUCONATE SODIUM;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; GRANULOMATOUS INFLAMMATION; HUMAN; LEISHMANIA BRAZILIENSIS; MALE; MICROSCOPY; NEUROTOXICITY; NOSE SURGERY; PARAMETER; PLASTIC SURGERY; POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS; SPECIES IDENTIFICATION; TIME; TREATMENT RESPONSE;

ANIMALS; ANTIPROTOZOAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DNA, PROTOZOAN; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 33846363896     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Zeegelaar JE, Steketee WH, Thiel PP van, Wetsteyn JC, Kager PA, Faber WR. Changing pattern of imported cutaneous leismaniasis in the Netherlands. Clin Exp Dermatol. 2005;30:1-5.
2. Mahboudi F, Abolhassani M, Tehrani SR, Azimi M, Asmar M. Differentiation of old and new world leishmania species at complex and species levels by PCR. Scand J Infect Dis. 2002;34:756-8.
3. Singh S, Sivakumar R. Recent advances in the diagnosis of leishmaniasis. J Postgrad Med. 2003;49:55-60.
4. Snoek E, Waard-van der Spek F, Hollander J den, Munte K, Sluiters J. Leishmaniasis: een vervelende vakantieherinnering. Nederlands Tijdschrift voor Dermatologie en Venereologie. 2005;15:283-9.
5. Vega-Lopez F. Diagnosis of cutaneous leishmaniasis. Curr Opin Infect Dis. 2003;16:97-101.
6. Eys GJ van, Schoone GJ, Kroon NC, Ebeling SB. Sequence analysis of small subunit ribosomal RNA genes and its use for detection and identification of Leishmania parasites. Mol Biochem Parasitol. 1992; 51:133-42.
7. Tavares CA, Fernandes AP, Melo MN. Molecular diagnosis of leishmaniasis. Expert Rev Mol Diagn. 2003;3:657-67.
8. Quinnell RJ, Courtenay O, Davidson S, Garcez L, Lambson B, Ramos P, et al. Detection of Leishmania infantum by PCR, serology and cellular immune response in a cohort study of Brazilian dogs. Parasitology. 2001;122(Pt 3):253-61.
9. Faber WR, Oskam L, Gool T van, Kroon NC, Knegt-Junk KJ, Hofwegen H, et al. Value of diagnostic techniques for cutaneous leishmaniasis. J Am Acad Dermatol. 2003;49:70-4.
10. Steenwinkel J de, Verweij J, Gyssens I. Diagnostiek van leishmaniasis. Nederlands Tijdschrift voor Medische Microbiologie. 2005;3:63-6.
11. Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodiumstibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 1992;46:296-306.
12. Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother. 2004;53:158-66.
13. Aronson NE, Wortmann GW, Johnson SC, Jackson JE, Gasser jr RA, Magill AJ, et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis. 1998527:1457-64.
14. Sands M, Kron MA, Brown RB. Pentamidine: a review. Rev Infect Dis. 1985;7:625-34.